Menu
Not yet recruiting NCT07468760

Peri-Implant Hard and Soft Tissue Changes After Immediate Implant Placement With Socket Shield and Immediate Restoration Versus Early Implant Placement in the Esthetic Zone

No phase Interventional Tooth Loss in the Anterior Maxilla Alveolar Bone Resorption Partial Edentulism of the Maxilla

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Socket Shield, Early Implant Placement.
Who it may be relevant to
Registry conditions: Tooth Loss in the Anterior Maxilla, Alveolar Bone Resorption, Partial Edentulism of the Maxilla. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Arab Emirates
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Evaluation of Peri-implant Hard And Soft Tissues Changes Between Immediate Implant Placement With Socket Shield Technique and Immediate Restoration Versus Early Type II Implant Placement in The Esthetic Zone - A Randomized Controlled Clinical Trial

Overview

This randomized controlled clinical trial aims to compare peri-implant hard and soft tissue dimensional changes following immediate implant placement with the socket shield technique and immediate restoration versus early type II implant placement with contour graft in the esthetic zone. The primary outcome is the Pink Esthetic Score (PES), while secondary outcomes include mid-facial mucosal recession, radiographic vertical and horizontal buccal bone remodeling, and patient satisfaction after 12 months.

Detailed description

Immediate implant placement is widely used for replacing non-restorable teeth in the esthetic zone. However, post-extraction remodeling of the buccal bone plate can lead to soft tissue recession and compromised esthetic outcomes. The socket shield technique has been proposed as a partial extraction therapy designed to preserve the buccal root fragment and maintain the facial bone and gingival architecture.

This single-center, prospective randomized controlled clinical trial aims to evaluate the effectiveness of the socket shield technique with immediate implant placement and immediate restoration compared with early type II implant placement with contour augmentation.

Forty-two patients requiring extraction of a single non-restorable tooth in the esthetic zone will be randomly allocated into two groups:

Test group: Immediate implant placement with socket shield technique and immediate restoration.

Control group: Early implant placement following soft tissue healing with contour augmentation.

Clinical, radiographic, and patient-reported outcomes will be assessed over a 12-month follow-up period.

Interventions

  • Procedure Socket Shield
    mmediate implant placement following partial extraction therapy using the socket shield technique. After decoronation and preparation of the buccal root fragment, the implant osteotomy will be created palatal to the retained root fragment to achieve correct prosthetic positioning. The gap between the implant and the root fragment will be filled with deproteinized bovine bone mineral, and an immediate provisional restoration will be placed using a PMMA temporary crown. Final implant-supported res
  • Procedure Early Implant Placement
    atraumatic extraction of the non-restorable tooth followed by early type II implant placement after a healing period of approximately 4-8 weeks. During implant surgery, a full-thickness flap will be elevated and the implant will be placed in the ideal prosthetic position. Contour augmentation will be performed using autogenous bone chips and deproteinized bovine bone mineral particles, which will be covered with a collagen membrane. After approximately 3 months of healing, the implant will be re

Primary outcome measures

  • Pink Esthetic Score (PES) [Time frame: 12 months after implant restoration]
Secondary outcome measures (4)
  • Peri-implant Mid-facial Mucosal Recession [Time frame: 12 months after implant placement]
  • Horizontal Radiographic Peri-implant Bone Changes [Time frame: 12 months after implant Restoration]
  • Vertical Radiographic Peri-implant Bone Changes [Time frame: 12 months after implant Restoration]
  • Patient Satisfaction [Time frame: 12 months after implant restoration]

Eligibility criteria

Inclusion criteria

  • Adults aged 18 years or older
  • Patients presenting with a single non-restorable tooth in the esthetic zone indicated for extraction and implant replacement
  • Presence of a thin buccal bone plate (<1 mm)
  • Adequate bone volume to allow implant placement in a prosthetically ideal position
  • Intact socket walls following tooth extraction
  • Ability to achieve primary implant stability ≥35 Ncm at the time of implant placement
  • Patients willing to participate in the study and able to provide written informed consent

Exclusion criteria

  • History of systemic diseases that may affect bone healing
  • Use of medications that may influence bone metabolism (e.g., bisphosphonates)
  • Smoking within the past 5 years
  • Presence of acute infection at the surgical site or adjacent teeth
  • Teeth with vertical or subcrestal horizontal root fractures on the buccal aspect
  • Presence of internal or external root resorption
  • Severe periodontal destruction at the implant site

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

United Arab Emirates · 1 center
  • Gulf Medical University — Ajman

Identifiers

NCT: NCT07468760 · IRB-COD-STD-87-Feb-2025 · IRB-COD-STD-87-Feb-2025

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗